Spyre Therapeutics, Inc. SYRE Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Spyre Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Spyre Therapeutics, Inc.’s 10-Q, filed May 8, 2025, on SEC EDGAR. View the filing →
Ask your AI about Spyre Therapeutics, Inc.'s price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Spyre Therapeutics, Inc.'s price / sales?
- Spyre Therapeutics, Inc. (SYRE) reported price / sales of 1,993× in Q1 2024.
- How has Spyre Therapeutics, Inc.'s price / sales changed year-over-year?
- Spyre Therapeutics, Inc.'s price / sales increased by 8393.8% year-over-year, from 23.5× to 1,993×.
- What is the long-term trend for Spyre Therapeutics, Inc.'s price / sales?
- Over 2 years (2021 to 2023), Spyre Therapeutics, Inc.'s price / sales has grown at a 623.2% compound annual growth rate (CAGR), from 16.7× to 874.9×.
- What does price / sales mean?
- How many dollars investors pay for each dollar of the company's annual sales.
- How do you interpret price / sales?
- Useful when earnings are negative or volatile (e.g. early-stage or cyclical firms). Only comparable across companies with similar margins — a sales dollar is worth more at a high-margin business.
- How does price / sales compare across companies?
- Best compared within a margin cohort; a software P/S and a retailer P/S are not directly comparable.